Paul Tudor Jones’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-70,447
| Closed | -$1.23M | – | 4312 |
|
|
2026
Q1 | $1.23M | Sell |
70,447
-39,239
| -36% | -$779K | ﹤0.01% | 2215 |
|
|
2025
Q4 | $2.15M | Buy |
109,686
+85,570
| +355% | +$1.78M | ﹤0.01% | 1762 |
|
|
2025
Q3 | $664K | Buy |
+24,116
| New | +$742K | ﹤0.01% | 2533 |
|
|
2025
Q1 | – | Sell |
-9,506
| Closed | -$341K | – | 3706 |
|
|
2024
Q4 | $341K | Buy |
+9,506
| New | +$356K | ﹤0.01% | 2507 |
|
|
2024
Q2 | – | Sell |
-28,175
| Closed | -$1.37M | – | 2826 |
|
|
2024
Q1 | $1.37M | Sell |
28,175
-5,731
| -17% | -$281K | 0.01% | 1199 |
|
|
2023
Q4 | $1.82M | Buy |
+33,906
| New | +$1.71M | 0.01% | 1148 |
|
|
2023
Q1 | – | Sell |
-12,047
| Closed | -$641K | – | 2983 |
|
|
2022
Q4 | $641K | Buy |
12,047
+2,028
| +20% | +$110K | 0.01% | 1426 |
|
|
2022
Q3 | $562K | Sell |
10,019
-8,208
| -45% | -$543K | 0.01% | 1313 |
|
|
2022
Q2 | $1.32M | Buy |
+18,227
| New | +$1.36M | 0.03% | 717 |
|
|
2021
Q4 | – | Sell |
-11,170
| Closed | -$1.03M | – | 3059 |
|
|
2021
Q3 | $1.03M | Buy |
11,170
+3,122
| +39% | +$300K | 0.02% | 1137 |
|
|
2021
Q2 | $824K | Sell |
8,048
-12,456
| -61% | -$1.25M | 0.02% | 942 |
|
|
2021
Q1 | $2M | Buy |
20,504
+8,330
| +68% | +$758K | 0.04% | 524 |
|
|
2020
Q4 | $939K | Sell |
12,174
-8,920
| -42% | -$690K | 0.03% | 714 |
|
|
2020
Q3 | $1.55M | Buy |
21,094
+3,084
| +17% | +$247K | 0.07% | 391 |
|
|
2020
Q2 | $1.32M | Buy |
18,010
+12,847
| +249% | +$1.01M | 0.07% | 385 |
|
|
2020
Q1 | $298K | Buy |
+5,163
| New | +$359K | 0.03% | 696 |
|
|
2019
Q3 | – | Sell |
-24,530
| Closed | -$1.95M | – | 1356 |
|
|
2019
Q2 | $1.95M | Sell |
24,530
-7,558
| -24% | -$599K | 0.06% | 338 |
|
|
2019
Q1 | $2.69M | Buy |
32,088
+27,497
| +599% | +$2.87M | 0.11% | 199 |
|
|
2018
Q4 | $540K | Sell |
4,591
-15,173
| -77% | -$1.75M | 0.01% | 571 |
|
|
2018
Q3 | $2.38M | Buy |
19,764
+2,126
| +12% | +$264K | 0.06% | 238 |
|
|
2018
Q2 | $2.03M | Buy |
17,638
+12,578
| +249% | +$1.38M | 0.07% | 250 |
|
|
2018
Q1 | $435K | Buy |
+5,060
| New | +$392K | 0.01% | 617 |
|
|
2017
Q4 | – | Sell |
-12,791
| Closed | -$738K | – | 1289 |
|
|
2017
Q3 | $738K | Buy |
12,791
+8,786
| +219% | +$519K | 0.02% | 505 |
|
|
2017
Q2 | $257K | Sell |
4,005
-10,813
| -73% | -$666K | 0.01% | 804 |
|
|
2017
Q1 | $854K | Buy |
14,818
+3,727
| +34% | +$222K | 0.03% | 451 |
|
|
2016
Q4 | $679K | Buy |
11,091
+4,683
| +73% | +$305K | 0.02% | 552 |
|
|
2016
Q3 | $443K | Buy |
+6,408
| New | +$423K | 0.01% | 793 |
|
|
2016
Q2 | – | Sell |
-6,000
| Closed | -$364K | – | 1946 |
|
|
2016
Q1 | $364K | Sell |
6,000
-4,600
| -43% | -$271K | 0.01% | 1168 |
|
|
2015
Q4 | $677K | Sell |
10,600
-200
| -2% | -$13K | 0.02% | 677 |
|
|
2015
Q3 | $724K | Buy |
+10,800
| New | +$764K | 0.02% | 549 |
|
|
2014
Q2 | – | Sell |
-16,800
| Closed | -$633K | – | 1328 |
|
|
2014
Q1 | $633K | Buy |
+16,800
| New | +$587K | 0.03% | 403 |
|
Other funds holding USNA
NCM
Paul Tudor Jones's USNA Position: Q2 2026 in Review
Paul Tudor Jones sold out of Usana Health Sciences (USNA) in Q2 2026, closing a stake of 70,447 shares — an estimated $1.23M sold.
Paul Tudor Jones first reported a position in USNA in Q1 2014 and held it in 31 quarters. The position peaked at $2.69M in Q1 2019. 137 funds tracked by Wall St. Rank hold USNA as of Q2 2026.
- Paul Tudor Jones reported no remaining Usana Health Sciences position as of Q2 2026 after selling out during the quarter.
- Paul Tudor Jones sold 70,447 Usana Health Sciences shares in Q2 2026, an estimated $1.23M.
- Paul Tudor Jones first reported a position in Usana Health Sciences in Q1 2014 and held it in 31 quarters.
- Paul Tudor Jones's Usana Health Sciences position peaked at $2.69M in Q1 2019.
- 137 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.
Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.